ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sartans Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-22J6899
Home | Market Reports | Health| Pharmacy
Global Sartans Market Insights and Forecast to 2028
BUY CHAPTERS

Global Sartans Market Research Report 2025

Code: QYRE-Auto-22J6899
Report
September 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol–Myers Squibb
Bayer
GSK
Teva Pharmaceutical

Sartans Market

The global market for Sartans was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Sartans are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
North American market for Sartans is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sartans is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Sartans include Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer, GSK, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sartans, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sartans.
The Sartans market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sartans market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sartans manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sartans Market Report

Report Metric Details
Report Name Sartans Market
Segment by Type
  • Valsartan
  • Telmisartan
  • Losartan
  • Irbesartan
  • Azilsartan
  • Olmesartan
Segment by Application
  • Hypertension
  • Cardiovascular Diseases
  • Kidney Diseases
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer, GSK, Teva Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sartans manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sartans in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Sartans Market report?

Ans: The main players in the Sartans Market are Pfizer, Novartis, Merck, Astra Zeneca, Jhonson and Johnson, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer, GSK, Teva Pharmaceutical

What are the Application segmentation covered in the Sartans Market report?

Ans: The Applications covered in the Sartans Market report are Hypertension, Cardiovascular Diseases, Kidney Diseases, Other

What are the Type segmentation covered in the Sartans Market report?

Ans: The Types covered in the Sartans Market report are Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan

1 Sartans Market Overview
1.1 Product Definition
1.2 Sartans by Type
1.2.1 Global Sartans Market Value Comparison by Type (2024 VS 2031)
1.2.2 Valsartan
1.2.3 Telmisartan
1.2.4 Losartan
1.2.5 Irbesartan
1.2.6 Azilsartan
1.2.7 Olmesartan
1.3 Sartans by Application
1.3.1 Global Sartans Market Value by Application (2024 VS 2031)
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 Global Sartans Market Size Estimates and Forecasts
1.4.1 Global Sartans Revenue 2020-2031
1.4.2 Global Sartans Sales 2020-2031
1.4.3 Global Sartans Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sartans Market Competition by Manufacturers
2.1 Global Sartans Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sartans Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sartans Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sartans, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sartans, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sartans, Product Type & Application
2.7 Global Key Manufacturers of Sartans, Date of Enter into This Industry
2.8 Global Sartans Market Competitive Situation and Trends
2.8.1 Global Sartans Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sartans Players Market Share by Revenue
2.8.3 Global Sartans Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sartans Market Scenario by Region
3.1 Global Sartans Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sartans Sales by Region: 2020-2031
3.2.1 Global Sartans Sales by Region: 2020-2025
3.2.2 Global Sartans Sales by Region: 2026-2031
3.3 Global Sartans Revenue by Region: 2020-2031
3.3.1 Global Sartans Revenue by Region: 2020-2025
3.3.2 Global Sartans Revenue by Region: 2026-2031
3.4 North America Sartans Market Facts & Figures by Country
3.4.1 North America Sartans Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sartans Sales by Country (2020-2031)
3.4.3 North America Sartans Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sartans Market Facts & Figures by Country
3.5.1 Europe Sartans Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sartans Sales by Country (2020-2031)
3.5.3 Europe Sartans Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sartans Market Facts & Figures by Region
3.6.1 Asia Pacific Sartans Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sartans Sales by Region (2020-2031)
3.6.3 Asia Pacific Sartans Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sartans Market Facts & Figures by Country
3.7.1 Latin America Sartans Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sartans Sales by Country (2020-2031)
3.7.3 Latin America Sartans Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sartans Market Facts & Figures by Country
3.8.1 Middle East and Africa Sartans Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sartans Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sartans Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sartans Sales by Type (2020-2031)
4.1.1 Global Sartans Sales by Type (2020-2025)
4.1.2 Global Sartans Sales by Type (2026-2031)
4.1.3 Global Sartans Sales Market Share by Type (2020-2031)
4.2 Global Sartans Revenue by Type (2020-2031)
4.2.1 Global Sartans Revenue by Type (2020-2025)
4.2.2 Global Sartans Revenue by Type (2026-2031)
4.2.3 Global Sartans Revenue Market Share by Type (2020-2031)
4.3 Global Sartans Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sartans Sales by Application (2020-2031)
5.1.1 Global Sartans Sales by Application (2020-2025)
5.1.2 Global Sartans Sales by Application (2026-2031)
5.1.3 Global Sartans Sales Market Share by Application (2020-2031)
5.2 Global Sartans Revenue by Application (2020-2031)
5.2.1 Global Sartans Revenue by Application (2020-2025)
5.2.2 Global Sartans Revenue by Application (2026-2031)
5.2.3 Global Sartans Revenue Market Share by Application (2020-2031)
5.3 Global Sartans Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Sartans Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Sartans Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Sartans Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Sartans Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Sartans Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Sartans Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Astra Zeneca
6.4.1 Astra Zeneca Company Information
6.4.2 Astra Zeneca Description and Business Overview
6.4.3 Astra Zeneca Sartans Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Astra Zeneca Sartans Product Portfolio
6.4.5 Astra Zeneca Recent Developments/Updates
6.5 Jhonson and Johnson
6.5.1 Jhonson and Johnson Company Information
6.5.2 Jhonson and Johnson Description and Business Overview
6.5.3 Jhonson and Johnson Sartans Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Jhonson and Johnson Sartans Product Portfolio
6.5.5 Jhonson and Johnson Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Company Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Sartans Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eli Lilly Sartans Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 Sanofi
6.7.1 Sanofi Company Information
6.7.2 Sanofi Description and Business Overview
6.7.3 Sanofi Sartans Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanofi Sartans Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Company Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Sartans Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bristol-Myers Squibb Sartans Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Sartans Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Sartans Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 GSK
6.10.1 GSK Company Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Sartans Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GSK Sartans Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Teva Pharmaceutical
6.11.1 Teva Pharmaceutical Company Information
6.11.2 Teva Pharmaceutical Description and Business Overview
6.11.3 Teva Pharmaceutical Sartans Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Teva Pharmaceutical Sartans Product Portfolio
6.11.5 Teva Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sartans Industry Chain Analysis
7.2 Sartans Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sartans Production Mode & Process Analysis
7.4 Sartans Sales and Marketing
7.4.1 Sartans Sales Channels
7.4.2 Sartans Distributors
7.5 Sartans Customer Analysis
8 Sartans Market Dynamics
8.1 Sartans Industry Trends
8.2 Sartans Market Drivers
8.3 Sartans Market Challenges
8.4 Sartans Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol–Myers Squibb
Bayer
GSK
Teva Pharmaceutical
List of Tables
 Table 1. Global Sartans Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sartans Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Sartans Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Sartans Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Sartans Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Sartans Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Sartans Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Sartans Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Sartans, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Sartans, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Sartans, Product Type & Application
 Table 12. Global Key Manufacturers of Sartans, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Sartans by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sartans as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sartans Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Sartans Sales by Region (2020-2025) & (K MT)
 Table 18. Global Sartans Sales Market Share by Region (2020-2025)
 Table 19. Global Sartans Sales by Region (2026-2031) & (K MT)
 Table 20. Global Sartans Sales Market Share by Region (2026-2031)
 Table 21. Global Sartans Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Sartans Revenue Market Share by Region (2020-2025)
 Table 23. Global Sartans Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Sartans Revenue Market Share by Region (2026-2031)
 Table 25. North America Sartans Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Sartans Sales by Country (2020-2025) & (K MT)
 Table 27. North America Sartans Sales by Country (2026-2031) & (K MT)
 Table 28. North America Sartans Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Sartans Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Sartans Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Sartans Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Sartans Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Sartans Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Sartans Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Sartans Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Sartans Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Sartans Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Sartans Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Sartans Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Sartans Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Sartans Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Sartans Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Sartans Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sartans Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Sartans Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Sartans Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Sartans Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Sartans Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Sartans Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Sartans Sales (K MT) by Type (2020-2025)
 Table 51. Global Sartans Sales (K MT) by Type (2026-2031)
 Table 52. Global Sartans Sales Market Share by Type (2020-2025)
 Table 53. Global Sartans Sales Market Share by Type (2026-2031)
 Table 54. Global Sartans Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Sartans Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Sartans Revenue Market Share by Type (2020-2025)
 Table 57. Global Sartans Revenue Market Share by Type (2026-2031)
 Table 58. Global Sartans Price (USD/MT) by Type (2020-2025)
 Table 59. Global Sartans Price (USD/MT) by Type (2026-2031)
 Table 60. Global Sartans Sales (K MT) by Application (2020-2025)
 Table 61. Global Sartans Sales (K MT) by Application (2026-2031)
 Table 62. Global Sartans Sales Market Share by Application (2020-2025)
 Table 63. Global Sartans Sales Market Share by Application (2026-2031)
 Table 64. Global Sartans Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Sartans Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Sartans Revenue Market Share by Application (2020-2025)
 Table 67. Global Sartans Revenue Market Share by Application (2026-2031)
 Table 68. Global Sartans Price (USD/MT) by Application (2020-2025)
 Table 69. Global Sartans Price (USD/MT) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Sartans Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Pfizer Sartans Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Sartans Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Novartis Sartans Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Sartans Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Merck Sartans Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Astra Zeneca Company Information
 Table 86. Astra Zeneca Description and Business Overview
 Table 87. Astra Zeneca Sartans Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Astra Zeneca Sartans Product
 Table 89. Astra Zeneca Recent Developments/Updates
 Table 90. Jhonson and Johnson Company Information
 Table 91. Jhonson and Johnson Description and Business Overview
 Table 92. Jhonson and Johnson Sartans Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Jhonson and Johnson Sartans Product
 Table 94. Jhonson and Johnson Recent Developments/Updates
 Table 95. Eli Lilly Company Information
 Table 96. Eli Lilly Description and Business Overview
 Table 97. Eli Lilly Sartans Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Eli Lilly Sartans Product
 Table 99. Eli Lilly Recent Developments/Updates
 Table 100. Sanofi Company Information
 Table 101. Sanofi Description and Business Overview
 Table 102. Sanofi Sartans Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Sanofi Sartans Product
 Table 104. Sanofi Recent Developments/Updates
 Table 105. Bristol-Myers Squibb Company Information
 Table 106. Bristol-Myers Squibb Description and Business Overview
 Table 107. Bristol-Myers Squibb Sartans Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. Bristol-Myers Squibb Sartans Product
 Table 109. Bristol-Myers Squibb Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer Sartans Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Bayer Sartans Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. GSK Company Information
 Table 116. GSK Description and Business Overview
 Table 117. GSK Sartans Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. GSK Sartans Product
 Table 119. GSK Recent Developments/Updates
 Table 120. Teva Pharmaceutical Company Information
 Table 121. Teva Pharmaceutical Description and Business Overview
 Table 122. Teva Pharmaceutical Sartans Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Teva Pharmaceutical Sartans Product
 Table 124. Teva Pharmaceutical Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Sartans Distributors List
 Table 128. Sartans Customers List
 Table 129. Sartans Market Trends
 Table 130. Sartans Market Drivers
 Table 131. Sartans Market Challenges
 Table 132. Sartans Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sartans
 Figure 2. Global Sartans Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sartans Market Share by Type: 2024 & 2031
 Figure 4. Valsartan Product Picture
 Figure 5. Telmisartan Product Picture
 Figure 6. Losartan Product Picture
 Figure 7. Irbesartan Product Picture
 Figure 8. Azilsartan Product Picture
 Figure 9. Olmesartan Product Picture
 Figure 10. Global Sartans Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Sartans Market Share by Application: 2024 & 2031
 Figure 12. Hypertension
 Figure 13. Cardiovascular Diseases
 Figure 14. Kidney Diseases
 Figure 15. Other
 Figure 16. Global Sartans Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Sartans Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Sartans Sales (2020-2031) & (K MT)
 Figure 19. Global Sartans Average Price (USD/MT) & (2020-2031)
 Figure 20. Sartans Report Years Considered
 Figure 21. Sartans Sales Share by Manufacturers in 2024
 Figure 22. Global Sartans Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Sartans Players: Market Share by Revenue in Sartans in 2024
 Figure 24. Sartans Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Sartans Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Sartans Sales Market Share by Country (2020-2031)
 Figure 27. North America Sartans Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Sartans Sales Market Share by Country (2020-2031)
 Figure 31. Europe Sartans Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Sartans Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Sartans Revenue Market Share by Region (2020-2031)
 Figure 39. China Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Sartans Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Sartans Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Sartans Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Sartans Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. U.A.E Sartans Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Sartans by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Sartans by Type (2020-2031)
 Figure 61. Global Sartans Price (USD/MT) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Sartans by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Sartans by Application (2020-2031)
 Figure 64. Global Sartans Price (USD/MT) by Application (2020-2031)
 Figure 65. Sartans Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Angiotensin Receptor Blockers ARBs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sartan series Drugs Market Research Report 2024
Global AT1 Receptor Antagonists Market Research Report 2024
Global Valsartan Tablets Market Research Report 2024
Angiotensin II Receptor Blocker ARBs API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
lrbesartan Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renin Angiotensin System RAS Inhibitor Market Research Report 2024
Valsartan Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Valsartan Hydrochlorothiazide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Valsartan Capsules Market Research Report 2024
Global Irbesartan Tablets Market Insights Forecast to 2030
Angiotensin Receptor Antagonists Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Irbesartan Market Research Report 2024
Global Enalapril Market Research Report 2024
Global Sacubitril Valsartan API Market Research Report 2025
Global Renin Inhibitors Market Research Report 2025
Global API of Sartan Drugs Market Research Report 2025
Global Angiotensin II Type 1 Receptor AT1R Antagonists Market Research Report 2024
Global Enalaprilat Market Research Report 2024
Global Enalapril Maleate Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions